JP2011057563A - Lytic agent - Google Patents
Lytic agent Download PDFInfo
- Publication number
- JP2011057563A JP2011057563A JP2009205456A JP2009205456A JP2011057563A JP 2011057563 A JP2011057563 A JP 2011057563A JP 2009205456 A JP2009205456 A JP 2009205456A JP 2009205456 A JP2009205456 A JP 2009205456A JP 2011057563 A JP2011057563 A JP 2011057563A
- Authority
- JP
- Japan
- Prior art keywords
- lactic acid
- acid bacteria
- bacteria
- treated product
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
本発明は、細菌性食中毒、食品の保存、化粧品の微生物汚染防止、家畜・家禽・養殖魚の疾病予防、衣服・物品の消毒、身体消毒・洗浄、植物疾病予防に関する。 The present invention relates to bacterial food poisoning, food preservation, prevention of microbial contamination of cosmetics, disease prevention of livestock, poultry and farmed fish, disinfection of clothes and articles, body disinfection and washing, and plant disease prevention.
食品・化粧品等の微生物汚染や増殖による弊害は、不十分な衛生状態・防腐対策を怠ることで、生じている。その対策は素材や調理の衛生状態の改善や微生物の一次汚染をなくすことが第一であるが、食品・化粧品の微生物増殖・汚染防止として、従来ソルビン酸、安息香酸及びその塩類、パラベン類の合成保存料、リゾチーム、リモネン、プロタミン、キトサン、ペクチン分解物、茶抽出物の天然系保存料が使用されている(特許文献1、2、3参照)。しかしながら、これらは安全性、刺激性、その効果、さらにその素材の色調、味覚において十分に満足させるものではない。 Defects caused by microbial contamination and proliferation of food and cosmetics are caused by negligent hygiene and antiseptic measures. The first countermeasure is to improve the hygienic condition of ingredients and cooking, and to eliminate primary contamination of microorganisms, but as a microbial growth and contamination prevention of foods and cosmetics, conventional sorbic acid, benzoic acid and its salts, parabens Synthetic preservatives, lysozyme, limonene, protamine, chitosan, pectin degradation products, and natural extracts of tea extract are used (see Patent Documents 1, 2, and 3). However, these are not satisfactory in terms of safety, irritation, its effect, color tone and taste of the material.
またヒトや動植物の微生物汚染防止または治療として、抗生物質が多量に使用され、人類史上それまで有効な治療方法のなかった多くの感染症が制圧され人類に大きな福音をもたらした。抗生物質はこのような特性からヒトばかりでなく家畜、家禽、養殖魚の細菌性の疾病に広く使用され、日本国内では年間約2000トンも使用されるようになり、このような抗生物質の乱用により耐性菌が増加し、ヒトの死亡率の増加、食への安全性の問題が生じている(非特許文献1) In addition, a large amount of antibiotics was used to prevent or treat microbial contamination of humans and animals and plants, and many infectious diseases that had not been effective in human history have been controlled, resulting in a great gospel. Antibiotics are widely used for bacterial diseases of not only humans but also livestock, poultry and farmed fish due to these characteristics, and about 2,000 tons are used annually in Japan. Resistant bacteria are increasing, resulting in increased human mortality and food safety issues (Non-patent Document 1)
乳酸菌は古来、食品保存、食品として長年使用され、最近では免疫賦活作用、整腸作用、コレステロール低減作用、抗腫瘍作用が注目され、健康維持のため幅広く飲用されるようになってきた(非特許文献2参照)。
そこで、微生物汚染を防ぐために、安全性の高く、健康に良いと言われている乳酸菌が検討されている(非特許文献3参照)。
Lactic acid bacteria have been used for many years as a food preservation and food since ancient times, and recently, immunostimulatory action, bowel regulation action, cholesterol reduction action, and antitumor action have attracted attention, and have been widely used for maintaining health (non-patented) Reference 2).
Therefore, in order to prevent microbial contamination, lactic acid bacteria that are said to be highly safe and healthy are being studied (see Non-Patent Document 3).
しかしながら、これらの乳酸菌は直接、微生物に対して作用を示すものではなく、乳酸菌を服用し、免疫機能を高め、IgAの作用により間接的に抗菌作用を示すものである。従ってその効果は軽微で食品添加物や直接微生物に対して作用もないことから用途は限定される。また、ストレプトコッカスの酵素前駆体組成物がグラム陽性菌の阻止および溶菌作用を示すことが報告されているが、これは菌体そのものではなく、菌体細胞質からの抽出成分である(非特許文献4)。 However, these lactic acid bacteria do not directly act on microorganisms, but take lactic acid bacteria to enhance immune function and indirectly exhibit antibacterial action by the action of IgA. Therefore, the use is limited because the effect is slight and it does not act on food additives or direct microorganisms. Moreover, although it has been reported that the enzyme precursor composition of Streptococcus exhibits inhibition of gram-positive bacteria and lytic action, this is not a cell itself but an extract component from the cell cytoplasm (Non-patent Document 4). ).
以上の事項から、細菌に対して耐性菌が生じることなく安全で使用感に影響を与えず、病原性微生物に対する抗菌作用を有する添加物の開発が望まれていた。 From the above matters, it has been desired to develop an additive having an antibacterial action against pathogenic microorganisms without causing resistance to bacteria and without affecting the feeling of use.
従って、本発明の目的は、ヒト、家畜、家禽、魚介類、植物に対して安全性が高く、微生物汚染、細菌性疾病に対処する溶菌作用を有する添加剤を提供することにある。 Accordingly, an object of the present invention is to provide an additive having a high lysis effect for humans, livestock, poultry, seafood and plants, and having a lytic action to cope with microbial contamination and bacterial diseases.
本発明者は上記目的を達成するために、すでに食経験からも安全性が確認されている乳酸菌に着目し、鋭意研究を重ねた結果、乳酸菌を培養し、菌体を超音波処理、ホモジナイザー粉砕もしくは凍結・融解のいずれの方法にて処理し、水、または生理食塩水で洗浄し、遠心分離後、細胞質を除いた細胞膜のみを凍結乾燥、もしくは低温乾燥して得られる乳酸菌処理物が病原性細菌を溶菌させるとの新知見を得、本発明を完成した。 In order to achieve the above object, the present inventor has paid attention to lactic acid bacteria that have been confirmed to be safe from dietary experience, and as a result of intensive research, cultured lactic acid bacteria, sonicated the cells, homogenizer pulverized Alternatively, treatment by freezing or thawing, washing with water or physiological saline, centrifuging, and then lyophilizing or cryogenic drying only the cell membrane excluding the cytoplasm. The present invention was completed by obtaining new knowledge that bacteria can be lysed.
本発明に乳酸菌処理物は顕著に病原性細菌の増殖を抑制した。本発明品は、食品・化粧料の防腐剤、家畜、家禽、養殖魚・海老飼料、植物病気予防剤、医薬品において上記目的のあらゆる分野に応用可能で、乳酸菌処理物を有効成分として食品、化粧品に配合すると微生物の増殖が抑制され、微生物の二次汚染や食中毒を予防・防止することが可能となった。また、家畜・家禽・魚介類の飼料として経口投与すると病原性細菌による疾患を予防・防止することが可能となり、その効果を発揮することができる。 In the present invention, the treated product of lactic acid bacteria significantly suppressed the growth of pathogenic bacteria. The product of the present invention can be applied to all fields for the above purposes in food / cosmetic preservatives, livestock, poultry, farmed fish / shrimp feed, plant disease preventives, and pharmaceuticals. When added to, the growth of microorganisms was suppressed, and secondary contamination and food poisoning of microorganisms could be prevented / prevented. Moreover, when it is orally administered as feed for livestock, poultry, and seafood, it becomes possible to prevent and prevent diseases caused by pathogenic bacteria, and to exert its effects.
本発明に用いられる乳酸菌はラクトバチルス(Lactobacillus)属、ペディオコッカス属(Pediococcus)、ラクトコッカス(Lacococcus)属、ロイコノストックス(Lueconostoc)属、ストレプトコッカス(Streptococcus)属、エンテロコッカス(Enterococcus)属及びワイセラ(Weissella)属等に属する乳酸菌を培養して得られる菌体の処理物からなる群より選ばれた1種又は2種以上である。 The lactic acid bacteria used in the present invention include the genus Lactobacillus, Pediococcus, Lacococcus, Leuconostoc, Streptococcus, Enterococcus, and Weicella. (Weissella) is one or more selected from the group consisting of processed microbial cells obtained by culturing lactic acid bacteria belonging to the genus and the like.
上記の本発明の乳酸菌の処理物調製法は、菌体を破砕し、細胞質を除去し、細胞膜を得るものである。従って菌の増殖能はない。その処理方法および乳酸菌の種類は特に制限されるものではないが、その例としては、先ずラクトバチルス属、ラクトコッカス属、ペディオコッカス属、ロイコノストックス属、ストレプトコッカス属、エンテロコッカス及びワイセラ属等に属する乳酸菌をその乳酸菌に適した培地を用いて培養する。その後、培地と菌体を遠心分離器にて分離し、水、または生理食塩水にて洗浄し、菌体を得る。さらに菌体を水、または生理食塩水に懸濁し、超音波、ホモジナイザー、凍結・融解法にて菌体膜を破壊する。その後遠心分離・洗浄工程を経て、乳酸菌の細胞菌のみを得る。これを凍結乾燥および低温乾燥にて乳酸菌処理物を得る。必要ならば工程中に溶菌効果低下に影響を及ぼさない範囲で更に、細胞膜の純度を向上させるために活性炭、シリカゲル、イオン交換樹脂等を使用し、脱臭、脱色等の精製処理をしても良い。 In the method for preparing a treated product of lactic acid bacteria of the present invention, the cells are crushed, the cytoplasm is removed, and a cell membrane is obtained. Therefore, there is no growth ability of bacteria. The treatment method and the type of lactic acid bacteria are not particularly limited. The lactic acid bacteria to which it belongs are cultured using a medium suitable for the lactic acid bacteria. Thereafter, the medium and the bacterial cells are separated with a centrifuge and washed with water or physiological saline to obtain bacterial cells. Furthermore, the cells are suspended in water or physiological saline, and the cell membrane is destroyed by ultrasonic waves, a homogenizer, and a freezing / thawing method. Thereafter, only lactic acid bacteria cell bacteria are obtained through a centrifugation and washing step. This is freeze-dried and dried at low temperature to obtain a lactic acid bacteria-treated product. If necessary, activated carbon, silica gel, ion exchange resin, etc. may be used to improve the purity of the cell membrane as long as it does not affect the lysis effect reduction during the process, and purification treatment such as deodorization and decolorization may be performed. .
本発明で使用する乳酸菌にはラクトバチルス属、ラクトコッカス属、ペディオコッカス属、ロイコノストックス属、ストレプトコッカス属及びエンテロコッカス属等があるが、これらの属および種に限定されるものではない。ラクトバチルス属としては、ラクトバチルス・ファーメンタム、ラクトバチル・プランタム、スラクトバチルス・デルブルッキー、ラクトバチルス・カゼイ、ラクトバチルス・ペントーサス等がある。ラクトコッカス属としては、ラクトコッカスおよびラクチスクレモリス等がある。ペディオコッカス属としては、ペディオコッカス・ペントサセウス、ペディオコッカス・アシディラクティシ、ペディオコッカス・ヘパリナス等がある。 ロイコノストックス属としては、ロイコノストックス・ラクティス、ロイコノストック・メセンテロイデス、ロイコノストックス・メセンテロイデス等がある。ストレプトコッカス属としてはストレプトコッカス・ サーモフィラスがある。エンテロコッカス属にはエンテロコッカス・フェカリス、エンテロコッカス・フェシウム、ワイセラ属としては、ワイセラ・シバリア、ワイセラ・コンフューサ、ワイセラ・ヘレニカ、ワイセラ・カンドレリ、ワイセラ・マイナー、ワイセラ・パラメセンテロイデスまたは/およびワイセラ・タイランデンシス等を挙げることができる。 The lactic acid bacteria used in the present invention include, but are not limited to, the genus Lactobacillus, Lactococcus, Pediococcus, Leuconostoccus, Streptococcus, and Enterococcus. Examples of the genus Lactobacillus include Lactobacillus fermentum, Lactobacillus plantum, Sractobacillus delbruecki, Lactobacillus casei, Lactobacillus pentosus and the like. Examples of the genus Lactococcus include Lactococcus and Lactis cremoris. Examples of the genus Pediococcus include Pediococcus pentosaseus, Pediococcus acidilactici, Pediococcus heparinus and the like. Examples of the genus Leuconostoc include Leuconostoc lactis, Leuconostoc mesenteroides, Leuconostoc mesenteroides and the like. Streptococcus genus includes Streptococcus thermophilus. Enterococcus faecalis, Enterococcus faecium, Enterococcus faecium, and Weissella spp. Cis etc. can be mentioned.
これらの種に属する乳酸菌の中でも、ラクトバチルス・ファーメンタム キリシマ1R株、ペディオコッカス ペントサセウス キリシマ1C株、ラクトバチルス・ファーメンタム キリシマ3R株、ペディオコッカス・アシディラクティシ キリシマ2C株などがグラム陽性菌およびグラム陰性菌の病原菌に対して溶菌作用が強く好適である。なお、これらの菌株は下記の受託番号によりセンターに寄託されている。 Among the lactic acid bacteria belonging to these species, Lactobacillus fermentum Kirishima 1R strain, Pediococcus pentosaceus Kirishima 1C strain, Lactobacillus fermentum Kirishima 3R strain, Pediococcus asidilactis Kirishima 2C strain, etc. are Gram-positive Bacterial and gram-negative bacterial pathogens are strong and suitable. These strains are deposited at the center with the following accession numbers.
ラクトバチルス・ファーメンタム キリシマ1R (NITE P−784)
ペディオコッカス・ペントサセウス キリシマ1C (NITE P-787)
ラクトバチルス・ファーメンタム キリシマ3R (NITE P-786)
ペディオコッカス・アシディラクティシ キリシマ2C (NITE P-788)
Lactobacillus fermentum Kirishima 1R (NITE P-784)
Pediococcus pentosaceus Kirisima 1C (NITE P-787)
Lactobacillus fermentum Kirishima 3R (NITE P-786)
Pediococcus acidilactici Kirishima 2C (NITE P-788)
好ましい乳酸菌の培養方法の例としては、本発明に用いる培地は天然培地、合成培地、半合成培地などの培地がある。培地の窒素源としては肉エキス、ペプトン、グルテン、カゼイン、酵母エキス、アミノ酸等が使用できる。炭素源としてはグルコース、キシロース、フラクトース、イノシトール、デンプン、バガス、フスマ、糖蜜、グルセリン等が使用できる。この他に窒素源と炭素源を含むスキムミルク、またはその分解物、コーンスティープリカー、焼酎粕、大豆粕とその分解物も培地の成分の一成分として配合可能である。この他にミネラルやイオン化成分として鉄、マンガン、モリブデン、塩化マグネシウム、食塩、リン酸カリウム、硫酸アンモニウム等の成分の配合が可能である。さらに適宜乳酸菌の特性に応じて各種のビタミン、界面活性剤、有機酸、トマトジュースを添加できる。 As an example of a preferable method for cultivating lactic acid bacteria, the medium used in the present invention includes a natural medium, a synthetic medium, a semi-synthetic medium and the like. As the nitrogen source of the medium, meat extract, peptone, gluten, casein, yeast extract, amino acid and the like can be used. As the carbon source, glucose, xylose, fructose, inositol, starch, bagasse, bran, molasses, glycerin and the like can be used. In addition, skim milk containing a nitrogen source and a carbon source, or a decomposed product thereof, corn steep liquor, shochu, soybean meal and a decomposed product thereof can also be blended as one component of the medium. In addition to this, it is possible to mix components such as iron, manganese, molybdenum, magnesium chloride, sodium chloride, potassium phosphate, and ammonium sulfate as minerals and ionization components. Furthermore, various vitamins, surfactants, organic acids, and tomato juice can be added according to the characteristics of lactic acid bacteria.
培養温度は25℃〜45℃であるが、好ましくは約30〜37℃で、培養時間は約12〜48時で静置もしくは振とう培養でもよい。培地のpHは3〜7で、このましくはpH4〜6である。培養終了後、菌体を採取し、上記で示した方法にて処理し、溶菌作用を有する乳酸菌処理物を得る。 The culture temperature is 25 ° C. to 45 ° C., preferably about 30 to 37 ° C., and the culture time is about 12 to 48 hours. The pH of the medium is 3 to 7, preferably 4 to 6. After completion of the culture, the cells are collected and treated by the method described above to obtain a lactic acid bacterium treated product having a lytic action.
本発明の溶菌作用を有する乳酸菌処理物のその形態については、この有効成分を含む限り特に制限はなく、液状、ペースト状、ゲル状等のいずれの形態で用いることもできる。さらにデキストリン、乳糖、コーンスターチ、セルロース等の賦形薬で媒散して用いることもできる。 The form of the processed lactic acid bacterium having a lytic action of the present invention is not particularly limited as long as it contains this active ingredient, and can be used in any form such as liquid, paste, or gel. Further, it can be used after being dispersed with an excipient such as dextrin, lactose, corn starch, or cellulose.
以下、本発明の有効成分である溶菌作用を有する乳酸菌処理物の応用例について説明する。
(食中毒防止剤)
本発明の応用例の食中毒防止剤は、前記乳酸菌処理物を含有することを特徴とする。本発明の乳酸菌処理物を1日に10mg〜1gを摂取することでご飯、弁当の食材、飲料水、生菓子、玉子、サラダ、サンドイッチ、おにぎり等による食品による細菌性食中毒を防止、または軽微にすることができる。
Hereinafter, application examples of the processed lactic acid bacteria having a lytic action which is an active ingredient of the present invention will be described.
(Food poisoning prevention agent)
The food poisoning prevention agent of the application example of the present invention is characterized by containing the processed product of lactic acid bacteria. Ingestion of 10 mg to 1 g of the lactic acid bacterium treatment product of the present invention per day prevents or minimizes bacterial food poisoning caused by foods such as rice, bento ingredients, drinking water, raw confectionery, eggs, salads, sandwiches, rice balls, etc. be able to.
(食品保存剤)
本発明の応用例の食品保存剤は、前記乳酸菌処理物を含有することを特徴とする。本発明の乳酸菌処理物の食品における上記乳酸菌処理物の含有量は、食品中、乾燥固形分として0.01〜5.0質量%が好ましく、より好ましくは0.1〜1.0質量%である。この範囲であれば、食品の防腐効果により微生物の増殖を抑制し、賞味期限の延長効果に優れ、食中毒抑制効果や賞味期限の延長が可能で経時安定性の面からも良好なものが得られる。
(Food preservative)
The food preservative of the application example of the present invention is characterized by containing the processed product of lactic acid bacteria. The content of the lactic acid bacterium-treated product in the lactic acid bacterium-treated food product of the present invention is preferably 0.01 to 5.0% by mass, more preferably 0.1 to 1.0% by mass as a dry solid content in the food product. is there. Within this range, the growth of microorganisms is suppressed by the antiseptic effect of food, the effect of extending the expiration date is excellent, the effect of suppressing food poisoning and the extension of the expiration date can be achieved, and good in terms of stability over time can be obtained. .
本発明の乳酸菌処理物含有の食品は、食中毒、細菌による腐敗・変質防止成分として、常法に従い、通常の食品に使用され、配合することができる。例えば、ご飯、弁当の食材、飲料水、生菓子、玉子、サラダ、サンドイッチ、おにぎり、漬物等である。 The processed food containing lactic acid bacteria of the present invention can be used and blended as a food poisoning, bacterial spoilage / alteration-preventing ingredient according to conventional methods. For example, rice, lunch box ingredients, drinking water, fresh confectionery, eggs, salads, sandwiches, rice balls, pickles and the like.
また、本発明の乳酸菌処理物含有の食品には、天然の防腐剤であるプロタミン分解物、グリシン、ポリリジン、グレープ・フルーツシード・エキス等を本発明の効果を損なわない範囲で目的に応じて適宜加えることができる。 In addition, in the food containing a processed product of lactic acid bacteria of the present invention, protamine degradation products, glycine, polylysine, grapefruit seed extract, etc., which are natural preservatives, are appropriately selected according to the purpose within a range not impairing the effects of the present invention. Can be added.
(化粧品防腐剤)
本発明の応用例の化粧品防腐剤は、前記乳酸菌処理物を含有することを特徴とする。本発明の乳酸菌処理物の食品における上記乳酸菌処理物の含有量は、化粧品中、乾燥固形分として0.01〜5.0質量%(以下、単に「%」と記す)が好ましく、より好ましくは0.05〜1.0質量%である。この範囲であれば、化粧品の防腐効果により一次汚染および二次汚染による微生物増殖を抑制し、経時変化による化粧品の臭い、色調の変質を防止し、経時安定性の面からも良好なものが得られる。
(Cosmetic preservative)
A cosmetic preservative according to an application example of the present invention is characterized by containing the processed product of lactic acid bacteria. The content of the lactic acid bacterium-treated product in the lactic acid bacterium-treated food of the present invention is preferably 0.01 to 5.0% by mass (hereinafter simply referred to as “%”) as a dry solid content in cosmetics, and more preferably. It is 0.05-1.0 mass%. Within this range, the antiseptic effect of cosmetics prevents microbial growth due to primary and secondary contamination, prevents cosmetic odors and color changes due to changes over time, and provides good stability over time. It is done.
本発明の乳酸菌処理物含有の化粧品は、配合形態の例としては、特に限定されず、例えば、乳液、クリーム、化粧水、美容液、パック、洗浄料、メーキャップ化粧料、分散液、軟膏、液剤、エアゾール、貼付剤、パップ剤等のいずれの形態の化粧料であっても外用医薬品等であっても良い。 The cosmetic product containing the treated product of lactic acid bacteria of the present invention is not particularly limited as an example of the blending form. For example, emulsion, cream, lotion, cosmetic liquid, pack, cleaning agent, makeup cosmetic, dispersion liquid, ointment, liquid agent Any form of cosmetics such as aerosols, patches, cataplasms and the like may be used as external medicines.
また、本発明の乳酸菌処理物含有の化粧品には、天然の防腐剤であるプロタミン分解物、グリシン、ポリリジン、グレープ・フルーツシード・エキス等を本発明の効果を損なわない範囲で目的に応じて適宜加えることがで きる。 Further, in the cosmetic containing a processed product of lactic acid bacteria of the present invention, a protamine degradation product, glycine, polylysine, grapefruit seed extract, etc., which are natural preservatives, are appropriately selected according to the purpose within a range not impairing the effects of the present invention. Can be added.
(家畜、家禽、養殖魚飼料)
本発明の応用例の家畜、家禽、養殖魚飼料は、前記乳酸菌処理物を含有することを特徴とする。本発明の乳酸菌処理物の食品における上記乳酸菌処理物の含有量は、飼料中、乾燥固形分として0.01〜2.0質量%(以下、単に「%」と記す)が好ましく、より好ましくは0.1〜1.0質量%である。この範囲であれば、飼料の溶菌効果により牛、豚においては下痢の一因となっている大腸菌O157菌の増殖を抑制し、抗生物質投与量を大幅に減少可能な良好な飼料が得られる。
(Livestock, poultry, farmed fish feed)
The livestock, poultry, and cultured fish feed of application examples of the present invention are characterized by containing the processed lactic acid bacteria. The content of the lactic acid bacterium-treated product in the lactic acid bacterium-treated food of the present invention is preferably 0.01 to 2.0% by mass (hereinafter, simply referred to as “%”) as a dry solid content in feed, and more preferably. 0.1 to 1.0% by mass. If it is this range, the lysis effect of a feed will suppress the growth of colon_bacillus | E._coli O157 which contributes to diarrhea in a cow and a pig, and the favorable feed which can reduce antibiotic dosage significantly will be obtained.
次に製造例及び実施例を挙げて本発明を更に詳細に説明するが、本発明はこれらに何ら制約されるものではない。 EXAMPLES Next, although a manufacture example and an Example are given and this invention is demonstrated in detail, this invention is not restrict | limited at all by these.
[溶菌作用を有する乳酸菌処理物の製造]
[製造例1]
MRS培地にラクトバチルス・ファーメンタム キリシマ1Rをおおよそ108cfu/mLの前培養液を1.0v/v%になるように接種し、30℃で20時間培養した。得られた培養液を1万Gにて遠心分離し、菌体を分離した。さらに精製水洗浄と遠心分離を繰り返し、菌体を十分に洗浄した後、超音波処理し、細胞膜を破砕した。その後精製水で洗浄し、遠心分離後沈殿物を凍結乾燥し、乳酸菌処理物を得た。おおよそ培養液から0.10質量%の収率で淡黄色の乳酸菌処理物を得た。
[Production of lactic acid bacteria-treated product with lytic activity]
[Production Example 1]
MRS medium was inoculated with Lactobacillus fermentum Kirishima 1R in a preculture solution of approximately 10 8 cfu / mL at 1.0 v / v% and cultured at 30 ° C. for 20 hours. The obtained culture solution was centrifuged at 10,000 G to separate the cells. Further, purified water washing and centrifugation were repeated to sufficiently wash the cells, followed by sonication to disrupt the cell membrane. Thereafter, it was washed with purified water, and after centrifugation, the precipitate was lyophilized to obtain a treated product of lactic acid bacteria. A pale yellow lactic acid bacterium-treated product was obtained from the culture solution at a yield of approximately 0.10% by mass.
[製造例2]
MRS培地にラクトバチルス・ファーメンタム キリシマ3Rをおおよそ108cfu/mLの前培養液を1.0v/v%になるように接種し、35℃で20時間培養した。得られた培養液を1万Gにて遠心分離し、菌体を分離した。さらに精製水洗浄と遠心分離を繰り返し、菌体を十分に洗浄した後、超音波処理し、細胞膜を破砕した。その後精製水で洗浄し、遠心分離後沈殿物を凍結乾燥し、乳酸菌処理物を得た。おおよそ培養液から0.12質量%の収率で淡黄色の乳酸菌処理物を得た。
[Production Example 2]
MRS medium was inoculated with Lactobacillus fermentum Kirishima 3R in a preculture solution of approximately 10 8 cfu / mL at 1.0 v / v% and cultured at 35 ° C. for 20 hours. The obtained culture solution was centrifuged at 10,000 G to separate the cells. Further, purified water washing and centrifugation were repeated to sufficiently wash the cells, followed by sonication to disrupt the cell membrane. Thereafter, it was washed with purified water, and after centrifugation, the precipitate was lyophilized to obtain a treated product of lactic acid bacteria. A pale yellow lactic acid bacterium-treated product was obtained from the culture solution at a yield of approximately 0.12% by mass.
[製造例3]
MRS培地にラクトバチルス・ファーメンタム NBRC3071をおおよそ108cfu/mLの前培養液を1.0v/v%になるように接種し、30℃で20時間培養した。得られた培養液を1万Gにて遠心分離し、菌体を分離した。さらに精製水洗浄と遠心分離を繰り返し、菌体を十分に洗浄した後、超音波処理し、細胞膜を破砕した。その後精製水で洗浄し、遠心分離後沈殿物を凍結乾燥し、乳酸菌処理物を得た。おおよそ培養液から0.08質量%の収率で淡黄色の乳酸菌処理物を得た。
[Production Example 3]
MRS medium was inoculated with Lactobacillus fermentum NBRC3071 at approximately 10 8 cfu / mL of preculture at 1.0 v / v% and cultured at 30 ° C. for 20 hours. The obtained culture solution was centrifuged at 10,000 G to separate the cells. Further, purified water washing and centrifugation were repeated to sufficiently wash the cells, followed by sonication to disrupt the cell membrane. Thereafter, it was washed with purified water, and after centrifugation, the precipitate was lyophilized to obtain a treated product of lactic acid bacteria. A light yellow lactic acid bacterium-treated product was obtained from the culture solution at a yield of approximately 0.08% by mass.
[製造例4]
MRS培地にペディオコッカス・ペントサセウス キリシマ1Cをおおよそ108cfu/mLの前培養液を1.0v/v%になるように接種し、30℃で20時間培養した。得られた培養液を1万Gにて遠心分離し、菌体を分離した。さらに精製水洗浄と遠心分離を繰り返し、菌体を十分に洗浄した後、超音波処理し、細胞膜を破砕した。その後精製水で洗浄し、遠心分離後沈殿物を凍結乾燥し、乳酸菌処理物を得た。おおよそ培養液から0.09質量%の収率で淡黄色の乳酸菌処理物を得た。
[Production Example 4]
The MRS medium was inoculated with Pediococcus pentosaceus Kirishima 1C at approximately 10 8 cfu / mL in a preculture solution of 1.0 v / v% and cultured at 30 ° C. for 20 hours. The obtained culture solution was centrifuged at 10,000 G to separate the cells. Further, purified water washing and centrifugation were repeated to sufficiently wash the cells, followed by sonication to disrupt the cell membrane. Thereafter, it was washed with purified water, and after centrifugation, the precipitate was lyophilized to obtain a treated product of lactic acid bacteria. A pale yellow lactic acid bacterium-treated product was obtained from the culture solution at a yield of approximately 0.09% by mass.
[製造例5]
MRS培地にペディオコッカス・アシディラクティシ キリシマ2Cをおおよそ108cfu/mLの前培養液を1.0v/v%になるように接種し、30℃で20時間培養した。得られた培養液を1万Gにて遠心分離し、菌体を分離した。さらに精製水洗浄と遠心分離を繰り返し、菌体を十分に洗浄した後、凍結・融解法にて処理し、細胞膜を破砕した。その後精製水で洗浄し、遠心分離後沈殿物を凍結乾燥し、乳酸菌処理物を得た。おおよそ培養液から0.11質量%の収率で淡黄色の乳酸菌処理物を得た。
[Production Example 5]
The MRS medium was inoculated with Pediococcus acidilactici Kirishima 2C at a pre-culture solution of approximately 10 8 cfu / mL at 1.0 v / v% and cultured at 30 ° C. for 20 hours. The obtained culture solution was centrifuged at 10,000 G to separate the cells. Furthermore, after washing with purified water and centrifugation repeatedly, the cells were thoroughly washed and then treated by freezing / thawing to disrupt the cell membrane. Thereafter, it was washed with purified water, and after centrifugation, the precipitate was lyophilized to obtain a treated product of lactic acid bacteria. A pale yellow lactic acid bacterium-treated product was obtained from the culture solution at a yield of approximately 0.11% by mass.
[製造例6]
5w/v%スキムミルクをプロテアーゼで酵素分解し、オートクレーブ後、沈殿物を除去したものを培地とし、これに製造例MRS培地にラクトバチルス・ファーメンタム キリシマ1Rをおおよそ108cfu/mLの前培養液を1.0v/v%になるように接種し、30℃で20時間培養した。得られた培養液を1万Gにて遠心分離し、菌体を分離した。さらに精製水洗浄と遠心分離を繰り返し、菌体を十分に洗浄した後、超音波処理し、細胞膜を破砕した。その後精製水で洗浄し、遠心分離後沈殿物を凍結乾燥し、乳酸菌処理物を得た。おおよそ培養液から0.09質量%の収率で白色の乳酸菌処理物を得た。
[Production Example 6]
Enzymatic degradation of 5 w / v% skimmed milk with protease, autoclaved, and the precipitate removed is used as a medium. To this, Lactobacillus fermentum Kirishima 1R is pre-cultured at approximately 10 8 cfu / mL. Was inoculated at 1.0 v / v% and cultured at 30 ° C. for 20 hours. The obtained culture solution was centrifuged at 10,000 G to separate the cells. Further, purified water washing and centrifugation were repeated to sufficiently wash the cells, followed by sonication to disrupt the cell membrane. Thereafter, it was washed with purified water, and after centrifugation, the precipitate was lyophilized to obtain a treated product of lactic acid bacteria. A white lactic acid bacterium-treated product was obtained from the culture solution at a yield of approximately 0.09% by mass.
[製造例7]
5w/v%スキムミルクをプロテアーゼで酵素分解し、オートクレーブ後、沈殿物を除去したものを培地とし、これにペディオコッカス・ペントサセウス キリシマ1C おおよそ108cfu/mLの前培養液を1.0v/v%になるように接種し、35℃で20時間培養した。得られた培養液を1万Gにて遠心分離し、菌体を分離した。さらに精製水洗浄と遠心分離を繰り返し、菌体を十分に洗浄した後、超音波処理し、細胞膜を破砕した。その後精製水で洗浄し、遠心分離後沈殿物を凍結乾燥し、乳酸菌処理物を得た。おおよそ培養液から0.10質量%の収率で白色の乳酸菌処理物を得た。
[Production Example 7]
5 w / v% skim milk is enzymatically decomposed with protease, and after autoclaving, the precipitate is removed as a medium, and Pediococcus pentosaseus Kirishima 1C is pre-cultured with about 10 8 cfu / mL of 1.0 v / v. % And inoculated at 35 ° C. for 20 hours. The obtained culture solution was centrifuged at 10,000 G to separate the cells. Further, purified water washing and centrifugation were repeated to sufficiently wash the cells, followed by sonication to disrupt the cell membrane. Thereafter, it was washed with purified water, and after centrifugation, the precipitate was lyophilized to obtain a treated product of lactic acid bacteria. A white lactic acid bacterium-treated product was obtained from the culture solution at a yield of approximately 0.10% by mass.
[製造例8]
5w/v%スキムミルクをプロテアーゼで酵素分解し、オートクレーブ後、沈殿物を除去したものを培地とし、これにラクトバチルス・ファーメンタム NBRC3071をおおよそ108cfu/mLの前培養液を1.0v/v%になるように接種し、30℃で20時間培養した。得られた培養液を1万Gにて遠心分離し、菌体を分離した。さらに精製水洗浄と遠心分離を繰り返し、菌体を十分に洗浄した後、超音波処理し、細胞膜を破砕した。その後精製水で洗浄し、遠心分離後沈殿物を凍結乾燥し、乳酸菌処理物を得た。おおよそ培養液から0.011質量%の収率で白黄色の乳酸菌処理物を得た。
[Production Example 8]
Enzymatic degradation of 5 w / v% skim milk with protease, autoclaved, and the precipitate removed is used as a medium. Lactobacillus fermentum NBRC3071 is pre-cultured with about 10 8 cfu / mL of preculture at 1.0 v / v. % And inoculated at 30 ° C. for 20 hours. The obtained culture solution was centrifuged at 10,000 G to separate the cells. Further, purified water washing and centrifugation were repeated to sufficiently wash the cells, followed by sonication to disrupt the cell membrane. Thereafter, it was washed with purified water, and after centrifugation, the precipitate was lyophilized to obtain a treated product of lactic acid bacteria. A processed product of white and yellow lactic acid bacteria was obtained from the culture solution at a yield of approximately 0.011% by mass.
[製造例9]
5w/v%スキムミルクをプロテアーゼで酵素分解し、オートクレーブ後、沈殿物を除去したものを培地とし、これにペディオコッカス・アシディラクティシ キリシマ2Cをおおよそ108cfu/mLの前培養液を1.0v/v%になるように接種し、30℃で20時間培養した。得られた培養液を1万Gにて遠心分離し、菌体を分離した。さらに精製水洗浄と遠心分離を繰り返し、菌体を十分に洗浄した後、超音波処理し、細胞膜を破砕した。その後精製水で洗浄し、遠心分離後沈殿物を凍結乾燥し、乳酸菌処理物を得た。おおよそ培養液から0.08質量%の収率で白黄色の乳酸菌処理物を得た。
[Production Example 9]
5 w / v% skim milk is enzymatically decomposed with protease, and after autoclaving, the precipitate is removed as a medium, and Pediococcus acidilactici Kirishima 2C is pre-cultured with about 10 8 cfu / mL of preculture solution. It was inoculated to become 0 v / v% and cultured at 30 ° C. for 20 hours. The obtained culture solution was centrifuged at 10,000 G to separate the cells. Further, purified water washing and centrifugation were repeated to sufficiently wash the cells, followed by sonication to disrupt the cell membrane. Thereafter, it was washed with purified water, and after centrifugation, the precipitate was lyophilized to obtain a treated product of lactic acid bacteria. A white-yellow lactic acid bacterium-treated product was obtained from the culture solution at a yield of approximately 0.08% by mass.
[製造例10]
5w/v%スキムミルクをプロテアーゼで酵素分解し、オートクレーブ後、沈殿物を除去したものを培地とし、これにラクトバチルス・ファーメンタム キリシマ3Rをおおよそ108cfu/mLの前培養液を1.0v/v%になるように接種し、30℃で20時間培養した。得られた培養液を1万Gにて遠心分離し、菌体を分離した。さらに精製水洗浄と遠心分離を繰り返し、菌体を十分に洗浄した後、凍結・融解法にて処理し、細胞膜を破砕した。その後精製水で洗浄し、遠心分離後沈殿物を凍結乾燥し、乳酸菌処理物を得た。おおよそ培養液から0.10質量%の収率で白色の乳酸菌処理物を得た。
[Production Example 10]
Enzymatic degradation of 5 w / v% skim milk with protease, autoclaved, and the precipitate removed is used as a medium, and Lactobacillus fermentum Kirishima 3R is pre-cultured at about 10 8 cfu / mL with 1.0 v / ml. It inoculated so that it might become v%, and it culture | cultivated at 30 degreeC for 20 hours. The obtained culture solution was centrifuged at 10,000 G to separate the cells. Furthermore, after washing with purified water and centrifugation repeatedly, the cells were thoroughly washed and then treated by freezing / thawing to disrupt the cell membrane. Thereafter, it was washed with purified water, and after centrifugation, the precipitate was lyophilized to obtain a treated product of lactic acid bacteria. A white lactic acid bacterium-treated product was obtained from the culture solution at a yield of approximately 0.10% by mass.
[製造例11]
5w/v%スキムミルクをプロテアーゼで酵素分解し、オートクレーブ後、沈殿物を除去したものを培地とし、これにエンテロコッカス・フェカリス NBRC 3989をおおよそ108cfu/mLの前培養液を1.0v/v%になるように接種し、30℃で20時間培養した。得られた培養液を1万Gにて遠心分離し、菌体を分離した。さらに精製水洗浄と遠心分離を繰り返し、菌体を十分に洗浄した後、超音波処理し、細胞膜を破砕した。その後精製水で洗浄し、遠心分離後沈殿物を凍結乾燥し、乳酸菌処理物を得た。おおよそ培養液から0.09質量%の収率で淡黄色の乳酸菌処理物を得た。
[Production Example 11]
Enzymatic degradation of 5 w / v% skim milk with protease, autoclaved, and the precipitate removed is used as the medium. Enterococcus faecalis NBRC 3989 is pre-cultured at about 10 8 cfu / mL with 1.0 v / v%. And inoculated at 30 ° C. for 20 hours. The obtained culture solution was centrifuged at 10,000 G to separate the cells. Further, purified water washing and centrifugation were repeated to sufficiently wash the cells, followed by sonication to disrupt the cell membrane. Thereafter, it was washed with purified water, and after centrifugation, the precipitate was lyophilized to obtain a treated product of lactic acid bacteria. A pale yellow lactic acid bacterium-treated product was obtained from the culture solution at a yield of approximately 0.09% by mass.
[製造例12]
MRS培地にペディオコッカス・ペントサセウス NBRC 3182をおおよそ108cfu/mLの前培養液を1.0v/v%になるように接種し、35℃で20時間培養した。得られた培養液を1万Gにて遠心分離し、菌体を分離した。さらに精製水洗浄と遠心分離を繰り返し、菌体を十分に洗浄した後、凍結・融解法にて処理し、細胞膜を破砕した。その後精製水で洗浄し、遠心分離後沈殿物を凍結乾燥し、乳酸菌処理物を得た。おおよそ培養液から0.12質量%の収率で淡黄色の乳酸菌処理物を得た。
[Production Example 12]
MRS medium was inoculated with Pediococcus pentosaceus NBRC 3182 at approximately 10 8 cfu / mL of preculture at 1.0 v / v% and cultured at 35 ° C. for 20 hours. The obtained culture solution was centrifuged at 10,000 G to separate the cells. Furthermore, after washing with purified water and centrifugation repeatedly, the cells were thoroughly washed and then treated by freezing / thawing to disrupt the cell membrane. Thereafter, it was washed with purified water, and after centrifugation, the precipitate was lyophilized to obtain a treated product of lactic acid bacteria. A pale yellow lactic acid bacterium-treated product was obtained from the culture solution at a yield of approximately 0.12% by mass.
[製造例13]
5w/v%スキムミルクをプロテアーゼで酵素分解し、オートクレーブ後、沈殿物を除去したものを培地とし、これにラクトバチルス・ラクティス 亜種 ラクティス NBRC12007をおおよそ108cfu/mLの前培養液を1.0v/v%になるように接種し、30℃で20時間培養した。得られた培養液を1万Gにて遠心分離し、菌体を分離した。さらに精製水洗浄と遠心分離を繰り返し、菌体を十分に洗浄した後、凍結・融解法にて処理し、細胞膜を破砕した。その後精製水で洗浄し、遠心分離後沈殿物を凍結乾燥し、乳酸菌処理物を得た。おおよそ培養液から0.08質量%の収率で白色の乳酸菌処理物を得た。
[Production Example 13]
The 5w / v% skim milk and enzymatic degradation with a protease, 1.0 v after autoclaving, that is obtained by removing the precipitate as the media, which in a preculture of approximately 10 8 cfu / mL Lactobacillus lactis subsp NBRC12007 / V%, and inoculated at 30 ° C. for 20 hours. The obtained culture solution was centrifuged at 10,000 G to separate the cells. Furthermore, after washing with purified water and centrifugation repeatedly, the cells were thoroughly washed and then treated by freezing / thawing to disrupt the cell membrane. Thereafter, it was washed with purified water, and after centrifugation, the precipitate was lyophilized to obtain a treated product of lactic acid bacteria. A white lactic acid bacterium-treated product was obtained from the culture solution at a yield of approximately 0.08% by mass.
1.溶菌乳酸菌処理物に使用した乳酸菌の特性
前記の製造例で使用した寄託乳酸菌株の菌学的特性を細菌検査用キットApi 50 CH(bio Merieux社製)を使用して調べた。結果を表1〜4に示す。
1. Characteristics of Lactic Acid Bacteria Used in Treated Lysate Lactic Acid Bacteria The bacteriological characteristics of the deposited lactic acid bacteria used in the above production examples were examined using a bacterial test kit Api 50 CH (manufactured by bio Merieux). The results are shown in Tables 1-4.
2.乳酸菌の遺伝学的特性
前記の製造例で使用した寄託乳酸菌株について常法に従い16S rDNAの塩基配列を決定し、既存のデータベースから既存菌種との相同性検索を行った。その結果、乳酸菌キリシマ1R株および乳酸菌キリシマ3R株はラクトバチルス・ファーメンタム、乳酸菌キリシマ1C株および乳酸菌キリシマ2C株はペディオコッカス・ペントサセウス(Pediococcus pentosaceus)とペディオコッカス・アシディラクティシ(Pediococcus acidilactici)であると同定された。
2. Genetic characteristics of lactic acid bacteria The base sequence of 16S rDNA was determined according to a conventional method for the deposited lactic acid bacteria used in the above production examples, and homology searches with existing bacterial species were performed from existing databases. As a result, the lactic acid bacteria Kirishima 1R strain and the lactic acid bacteria Kirishima 3R strain are Lactobacillus fermentum, and the lactic acid bacteria Kirishima 1C strain and the lactic acid bacteria Kirishima 2C strain are Pediococcus pentosaceus and Pediococcus acidilactici (acidic acidi). ).
3.乳酸菌処理物による黄色ブドウ球菌および大腸菌の溶菌作用
下記方法により乳酸菌処理物の溶菌作用を評価した。
(溶菌試験方法)
黄色ブドウ球菌および大腸菌の乳酸菌処理物の溶菌作用試験は次の順序で行った。先ず培地に2%トリプトソイブイヨン培地(ベクトンディキンソン社)を用い、黄色ブドウ球菌および大腸菌を106〜107cfu/mLに調製し、乳酸菌処理物を波長620nmにて吸光値0.01なるように添加した。調製した試料をマイクロプレートの96ウェルに分注し、30℃で培養し、プレートリーダーで経時的に吸光値:濁度(620nm)を測定した。0時間の濁度を基準として620nmの吸光値で溶菌作用を表した。
3. Lysis of Staphylococcus aureus and Escherichia coli by treated lactic acid bacteria The lytic activity of the treated lactic acid bacteria was evaluated by the following method.
(Bacteria test method)
The lytic action test of the processed lactic acid bacteria of Staphylococcus aureus and Escherichia coli was performed in the following order. First, using a 2% tryptic soy bouillon medium (Becton Dickinson) as the medium, S. aureus and Escherichia coli are prepared at 10 6 to 10 7 cfu / mL, and the lactic acid bacteria treated product has an absorbance value of 0.01 at a wavelength of 620 nm. Added to. The prepared sample was dispensed into 96 wells of a microplate, cultured at 30 ° C., and the absorbance value: turbidity (620 nm) was measured over time with a plate reader. Lysis was expressed as an absorbance value at 620 nm with reference to 0 hour turbidity.
実施例1:製造例1、2、3、4、5で示す乳酸菌処理物を培地に0.01W/v%添加し、黄色ブドウ球菌を播種し、溶菌作用試験を行った。
(グラム陽性菌の溶菌作用)
5,10、20時間後の吸光値の結果について表5に示した。
Example 1: The processed lactic acid bacteria shown in Production Examples 1, 2, 3, 4 and 5 were added to the medium in an amount of 0.01 W / v%, seeded with Staphylococcus aureus, and a lysis test was performed.
(Bacterial action of Gram-positive bacteria)
The results of absorbance values after 5, 10 and 20 hours are shown in Table 5.
実施例2:製造例1(本発明品)、2(本発明品)、3(本発明品)、4(本発明品)、5(本発明品)で示す乳酸菌処理物を培地に0.01W/v%添加し、大腸菌を播種し、溶菌作用試験を行った。
(グラム陰性菌の溶菌作用)
5,10、20時間後の吸光値の結果について表6に示した。
Example 2: Preparation of lactic acid bacteria shown in Production Example 1 (Invention product), 2 (Invention product), 3 (Invention product), 4 (Invention product), and 5 (Invention product) 01 W / v% was added, E. coli was inoculated, and a lysis test was performed.
(Bacterial action of Gram-negative bacteria)
The results of absorbance values after 5, 10, and 20 hours are shown in Table 6.
(結果)
黄色ブドウ球菌では1時間経過すると乳酸菌処理物による溶菌作用が認められ、5時間経過すると各試料とも培地が澄明になり、顕著な溶菌作用が認められた。20時間経過するとほぼ溶菌は完了した。乳酸菌の超音波処理と凍結・融解処理には大きな違い認められなく、双方とも同様な効果が認められた。さらにグラム陰性菌である大腸菌においても同様に溶菌作用が認められた。
(result)
In Staphylococcus aureus, the lysis effect by the processed lactic acid bacteria was observed after 1 hour, and after 5 hours, the culture medium of each sample became clear and a remarkable lysis effect was recognized. After 20 hours, lysis was almost complete. There was no significant difference between the ultrasonic treatment of lactic acid bacteria and the freezing / thawing treatment, and the same effect was observed in both cases. Furthermore, the lytic action was similarly observed in Escherichia coli, which is a gram-negative bacterium.
表5および表6から明らかなように、乳酸菌無添加のコントロールは病原性細菌が増殖し、吸光値が増加した。一方、本発明に用いられる乳酸菌処理物添加の培養試料は経時的に吸光値の低下が認められいずれも顕著な溶菌作用を示した。これらの乳酸菌処理物の溶菌効果は極めて優れたものであった。 As is clear from Tables 5 and 6, in the control without addition of lactic acid bacteria, pathogenic bacteria grew and the absorbance value increased. On the other hand, the culture samples added with the treated lactic acid bacteria used in the present invention showed a decrease in absorbance over time, and all showed remarkable lytic activity. The lysis effect of these treated lactic acid bacteria was extremely excellent.
本発明は安全性の高い乳酸菌処理物で、病原性細菌を溶菌することができる。その結果、細菌性疾患を予防若しくは防止及び食品や化粧品等への微生物の二次汚染を防止する可能性があり、食品、医療、化粧品、家畜飼料関係業界などにおいて有用である。
The present invention is a highly safe treated product of lactic acid bacteria that can lyse pathogenic bacteria. As a result, there is a possibility of preventing or preventing bacterial diseases and preventing secondary contamination of microorganisms in foods, cosmetics, etc., which is useful in food, medical, cosmetics, livestock feed industries and the like.
Claims (4)
The lysis agent of Claim 3 which contains 0.01 mass% or more of said processed products of lactic acid bacteria.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009205456A JP2011057563A (en) | 2009-09-07 | 2009-09-07 | Lytic agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009205456A JP2011057563A (en) | 2009-09-07 | 2009-09-07 | Lytic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2011057563A true JP2011057563A (en) | 2011-03-24 |
Family
ID=43945639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009205456A Pending JP2011057563A (en) | 2009-09-07 | 2009-09-07 | Lytic agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2011057563A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116711852A (en) * | 2023-06-09 | 2023-09-08 | 天津科技大学 | Preparation method of soy sauce rich in probiotics and probiotic soy sauce |
-
2009
- 2009-09-07 JP JP2009205456A patent/JP2011057563A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116711852A (en) * | 2023-06-09 | 2023-09-08 | 天津科技大学 | Preparation method of soy sauce rich in probiotics and probiotic soy sauce |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6953574B2 (en) | Method for producing a fermented hydrolyzed medium containing microorganisms | |
KR101759149B1 (en) | Powdery malted rice extract composition | |
CN101679935B (en) | Novel bacteria isolated from fresh honey or the honey producing tract of honey bees | |
KR101369219B1 (en) | Antibacterial tyndalized lactic acid bacteria and preparing method thereof | |
JP5791009B2 (en) | Lactic acid bacteria and food or drink using them | |
CN104277998A (en) | Use and methods for preventing and/or treating oral malodour | |
KR101164876B1 (en) | Broccoli production fermented by lactic acid bacteria, which is anti-inflammatory and anti-Helicobacter pylori and method for preparation thereof | |
KR101372200B1 (en) | Lactobacillus plantarum SY99 and Use Thereof | |
KR20060135016A (en) | Compostion comprising yucca extract, quillaia extract and lactic acid bacterium and food and drink containing the composition | |
KR102052047B1 (en) | Pediococcus pentosaceus having antibacterial activity and uses thereof | |
KR101959730B1 (en) | Staphylococcus gallinarum strain with antibiotic activity and antibiotic use thereof | |
KR102178350B1 (en) | Bacillus safensis strain with antibiotic activity and antibiotic use thereof | |
KR102313770B1 (en) | LACTOBACILLUS PLANTARUM WiKim0127 STRAIN DERIVED FROM JEJU PICKLED CABBAGE FOOD AND METHOD FOR PREPARING COMPOSITION USING SAME | |
Negm | Classification, antimicrobial potential, industrial applications and probiotic capability of lactic acid bacteria: A review article | |
N’tcha et al. | Probiotic properties of lactic acid bacteria isolated from a beninese traditional beer’s ferment | |
TWI679982B (en) | Use of lactic acid bacteria fermented material for producing inhibitor of pentosine | |
KR102313769B1 (en) | Lactobacillus plantarum wikim0126 strain derived from jeju pickled brussels sprout food and method for preparing composition using same | |
KR102332021B1 (en) | Manufacturing method for aminobiotics using medium comprising A2 beta casein, and amniobiotics prepared therethrough | |
JP2011057563A (en) | Lytic agent | |
KR20220092787A (en) | A novel Lactobacillus paracasei strain and uses thereof | |
KR101959729B1 (en) | Bacillus Pumilus strain with antibiotic activity and antibiotic use thereof | |
KR101332420B1 (en) | Novel Leuconostoc citreum BS14 producing class II bacteriocin isolated from kimchi and use of the same | |
KR102457366B1 (en) | Lactobacillus plantarum wikim0127 strain derived from jeju pickled cabbage food and method for preparing composition using same | |
KR102457367B1 (en) | Lactobacillus plantarum wikim0126 strain derived from jeju pickled brussels sprout food and method for preparing composition using same | |
KR102390839B1 (en) | Staphylococcus-derived antibacterial substance mixture against Staphylococcus aureus and uses thereof |